Viral Vitalism

Rapid Briefs

The source-backed signal desk for health stories before they become obvious.

VV catches the signal early, explains it cleanly, shows the source trail, and tells you what not to overclaim.

Filtered signal trail

Tag: diabetes

Clear filter
Device SafetyConfirmed

FDA Flagged a Serious Omnipod Insulin-Delivery Recall

Certain Omnipod Pods may leak insulin because of a cannula tear, creating under-delivery risk that can lead to hyperglycemia or diabetic ketoacidosis.

Why now

FDA's Class I classification makes this an urgent patient-safety story for insulin-dependent diabetes users who may have affected Pods.

Overclaim risk
high
Primary source
Official
Published
Jul 5, 2026
Read brief ->
Drug SafetyReported

GLP-1 Drugs Linked to Higher Smell and Taste Disturbance Risk

A large EHR cohort study found GLP-1 RA users with type 2 diabetes had higher documented smell and taste disturbance risk, though absolute rates were low.

Why now

GLP-1 safety signals are socially viral and need careful absolute-risk framing.

Overclaim risk
medium-high
Primary source
Primary
Published
Jun 30, 2026
Read brief ->